Literature Review: COVID-19 Management at Family Medicine Outpatient Clinics

Authors

  • Dr. Hamad AlSubaie Family Medicine Department, King Abdulaziz Hospital, Kingdom of Saudi Arabia, Eastern Region, AlHassa
  • Dr. Mansour AlNaim Family Medicine, King Abdulaziz Hospital, AlHassa
  • Dr. Sara AlSubaie Family Medicine, Primary Health Center of National Guard Health Affair, AlHassa

Keywords:

COVID 19, corona virus, family medicine, outpatient clinics, management

Abstract

COVID-19 is a worldwide medical problem affecting majority of people with different age groups, where family medicine outpatient clinics is the first line in detecting and managing this medical issue, we tried to put our hands to explore the way of management of COVID-19 at the family medicine outpatient clinics where it’s containing mainly supportive treatment in addition to Paxlovid, Molnupiravir as required and as needed according to the patient and his medical condition.

References

L.E. van Eijk, M. Binkhorst, A.R. Bourgonje, A.K. Offringa, D.J. Mulder, E.M. Bos, N. Kolundzic, A.E. Abdulle, P.H. van der Voort, M.G. Olde Rikkert, J.G. van der Hoeven, W.F. den Dunnen, J.L. Hillebrands and H. van Goor. “COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.” The Journal of Pathology, vol. 254, pp. 307-331, Jul. 2021.

B. Mash. “Primary care management of the coronavirus (COVID-19).” South African Family Practice: Official Journal of the South African Academy of Family Practice/Primary Care, vol. 62, pp. e1-e4, Mar. 2020.

S. Umakanthan, P. Sahu, A.V. Ranade, M.M. Bukelo, J.S. Rao, L.F. Abrahao-Machado, S. Dahal, H. Kumar and D. Kv. “Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19).” Postgraduate Medical Journal, vol. 96, pp. 753-758, Dec. 2020.

E. Mahase. “COVID-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports.” British Medical Journal (Clinical research ed.), vol. 375, pp. n2713, Nov. 2021.

A.K. Singh, A. Singh, R. Singh and A. Misra. “Molnupiravir in COVID-19: a systematic review of literature.” Diabetes & Metabolic Syndrome, vol, 15, pp. 102329, Nov. 2021.

T.C. Theoharides and P. Conti. “Dexamethasone for COVID-19? Not so fast.” Journal of Biological Regulators and Homeostatic Agents, vol. 34, pp. 1241-1243, Jul-Aug. 2020.

M.M. Aleissa, E.A. Silverman, L.M. Paredes Acosta, C.T. Nutt, A. Richterman and F.M. Marty. “New perspectives on antimicrobial agents: remdesivir treatment for COVID-19.” Antimicrobial Agents and Chemotherapy, vol. 65, pp. e01814-e01820, Dec. 2020.

Downloads

Published

2022-07-16

How to Cite

AlSubaie, H., AlNaim, M., & AlSubaie, S. (2022). Literature Review: COVID-19 Management at Family Medicine Outpatient Clinics. International Journal of Sciences: Basic and Applied Research (IJSBAR), 63(1), 71–72. Retrieved from https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/14273

Issue

Vol. 63 No. 1 (2022)

Section

Articles

License

Copyright (c) 2022 International Journal of Sciences: Basic and Applied Research (IJSBAR)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who submit papers with this journal agree to the following terms.